Laura Benjamin
Director/Miembro de la Junta en ALLARITY THERAPEUTICS, INC. .
Cargos activos de Laura Benjamin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ALLARITY THERAPEUTICS, INC. | Director/Miembro de la Junta | - | - |
| Independent Dir/Board Member | - | - | |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Director/Miembro de la Junta | 01/01/2018 | - |
| Director Ejecutivo | 01/01/2018 | - | |
| Fundador | 01/01/2018 | - | |
| Presidente | 01/01/2018 | - | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Director/Miembro de la Junta | - | - |
| Independent Dir/Board Member | - | - |
Historial de carrera de Laura Benjamin
Formación de Laura Benjamin.
| University of Pennsylvania | Doctorate Degree |
| Barnard College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Dinamarca | 2 |
Operativa
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ALLARITY THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA. | Health Technology |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Laura Benjamin
- Experiencia
